» Articles » PMID: 31547042

Comprehensive Detection of Isopeptides Between Human Tissue Transglutaminase and Gluten Peptides

Overview
Journal Nutrients
Date 2019 Sep 25
PMID 31547042
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Celiac disease (CD) is a chronic inflammation of the small intestine triggered by the ingestion of gluten in genetically predisposed individuals. Tissue transglutaminase (TG2) is a key factor in CD pathogenesis, because it catalyzes both the deamidation of specific glutamine residues and the formation of covalent Nε-(γ-glutamyl)-lysine isopeptide crosslinks resulting in TG2-gluten peptide complexes. These complexes are thought to activate B cells causing the secretion of anti-TG2 autoantibodies that serve as diagnostic markers for CD, although their pathogenic role remains unclear. To gain more insight into the molecular structures of TG2-gluten peptide complexes, we used different proteomics software tools that enable the comprehensive identification of isopeptides. Thus, 34 different isopeptides involving 20 TG2 lysine residues were identified in a model system, only six of which were previously known. Additionally, 36 isopeptides of TG2-TG2 multimers were detected. Experiments with different TG2-gluten peptide molar ratios revealed the most preferred lysine residues involved in isopeptide crosslinking. Expanding the model system to three gluten peptides with more glutamine residues allowed the localization of the preferred glutamine crosslinking sites. These new insights into the structure of TG2-gluten peptide complexes may help clarify the role of extracellular TG2 in CD autoimmunity and in other inflammatory diseases.

Citing Articles

Comparative Label-Free Proteomics Study on Celiac Disease-Active Epitopes in Common Wheat, Spelt, Durum Wheat, Emmer, and Einkorn.

Norwig M, Geisslitz S, Scherf K J Agric Food Chem. 2024; 72(26):15040-15052.

PMID: 38906536 PMC: 11228976. DOI: 10.1021/acs.jafc.4c02657.


Did diet compliance and remission reduce oxidative stress in celiac patients?.

Ebik B, Bacaksiz F, Uzel A, Akkuzu M, Yavuz A, Kacmaz H Rev Assoc Med Bras (1992). 2024; 70(4):e20231120.

PMID: 38716937 PMC: 11068382. DOI: 10.1590/1806-9282.20231120.


Changes in Non-Deamidated versus Deamidated Epitope Targeting and Disease Prediction during the Antibody Response to Gliadin and Transglutaminase of Infants at Risk for Celiac Disease.

Dios A, Srinivasan B, Gyimesi J, Werkstetter K, Valenta R, Koletzko S Int J Mol Sci. 2022; 23(5).

PMID: 35269639 PMC: 8909931. DOI: 10.3390/ijms23052498.


Evaluation of mass spectrometry MS/MS spectra for the presence of isopeptide crosslinked peptides.

Schopfer L, Onder S, Lockridge O PLoS One. 2021; 16(7):e0254450.

PMID: 34242352 PMC: 8270460. DOI: 10.1371/journal.pone.0254450.


Age-associated proinflammatory elastic fiber remodeling in large arteries.

Kim S, Monticone R, McGraw K, Wang M Mech Ageing Dev. 2021; 196:111490.

PMID: 33839189 PMC: 8154723. DOI: 10.1016/j.mad.2021.111490.


References
1.
du Pre M, Sollid L . T-cell and B-cell immunity in celiac disease. Best Pract Res Clin Gastroenterol. 2015; 29(3):413-23. DOI: 10.1016/j.bpg.2015.04.001. View

2.
Koning F . Celiac disease: quantity matters. Semin Immunopathol. 2012; 34(4):541-9. PMC: 3410019. DOI: 10.1007/s00281-012-0321-0. View

3.
Iismaa S, Mearns B, Lorand L, Graham R . Transglutaminases and disease: lessons from genetically engineered mouse models and inherited disorders. Physiol Rev. 2009; 89(3):991-1023. DOI: 10.1152/physrev.00044.2008. View

4.
Fleckenstein B, Qiao S, Larsen M, Jung G, Roepstorff P, Sollid L . Molecular characterization of covalent complexes between tissue transglutaminase and gliadin peptides. J Biol Chem. 2004; 279(17):17607-16. DOI: 10.1074/jbc.M310198200. View

5.
Lu S, Fan S, Yang B, Li Y, Meng J, Wu L . Mapping native disulfide bonds at a proteome scale. Nat Methods. 2015; 12(4):329-31. DOI: 10.1038/nmeth.3283. View